In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus

J Antimicrob Chemother. 1983 Jan;11(1):21-6. doi: 10.1093/jac/11.1.21.

Abstract

Minimal inhibitory and minimal bactericidal concentrations were determined for eighteen methicillin-resistant Staphylococcus aureus isolates, the majority also resistant to gentamicin, obtained from the blood of bacteraemic patients. Fifty per cent of organisms had a greater than four-fold difference in M.I.C. and M.B.C. for vancomycin, 83% for rifampicin, and 89% for fusidic acid. In-vitro effects of two-drug combinations of vancomycin, rifampicin, and fusidic acid demonstrated neither synergy nor antagonism when measured by a checkerboard dilution technique. The relevance of these findings to choice of therapy of serious infection due to methicillin-gentamicin resistant Staph. aureus is yet to be determined.

MeSH terms

  • Culture Media
  • Fusidic Acid / pharmacology*
  • Methicillin / pharmacology
  • Microbial Sensitivity Tests
  • Penicillin Resistance
  • Rifampin / pharmacology*
  • Staphylococcus aureus / drug effects*
  • Vancomycin / pharmacology*

Substances

  • Culture Media
  • Fusidic Acid
  • Vancomycin
  • Methicillin
  • Rifampin